4.7 Article

Epidermal Growth Factor Tethered through Coiled-Coil Interactions Induces Cell Surface Receptor Phosphorylation

期刊

BIOCONJUGATE CHEMISTRY
卷 20, 期 8, 页码 1569-1577

出版社

AMER CHEMICAL SOC
DOI: 10.1021/bc9001147

关键词

-

资金

  1. Canada Research Chair on Protein-Enhanced Biomaterials
  2. Canada Research Chair in Applied Metabolic Engineering
  3. Natural Sciences and Engineering Research Council of Canada
  4. GRSTB

向作者/读者索取更多资源

We have elaborated and validated a novel approach for the oriented tethering of proteins such as the epidermal growth factor (EGF) oil aminated surfaces. The grafting reactions were optimized to generate a dense and homogeneous EGF layer. Impact of EGF orientation on A-431 cellular response was investigated. Our results demonstrate that, in sharp contrast to responses obtained with soluble EGF supply or with randomly grafted EGF, oriented immobilization of EGF via a de novo designed coiled-coil capture system leads to a sustained phosphorylation of A-431 cell surface EGF receptors. Our results thus indicate that oriented protein immobilization via coiled-coil interactions is an efficient: and versatile method to control tethering of bioactive molecules for future applications in the field of regenerative medicine and tissue engineering.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biotechnology & Applied Microbiology

High-level production of wild-type and oxidation-resistant recombinant alpha-1-antitrypsin in glycoengineered CHO cells

Izel Koyuturk, Surbhi Kedia, Anna Robotham, Alexandra Star, Denis Brochu, Janelle Sauvageau, John Kelly, Michel Gilbert, Yves Durocher

Summary: Alpha-1-antitrypsin (A1AT) is a protease inhibitor that protects the lungs from damage. A1AT deficiency increases the risk of lung diseases. Currently, the only treatment is weekly injection of plasma-purified A1AT. This study aimed to produce recombinant A1AT with N-glycans similar to plasma-derived A1AT. By disrupting glycosyltransferase genes and overexpressing sialyltransferase, high levels of recombinant A1AT with desired glycosylation were obtained.

BIOTECHNOLOGY AND BIOENGINEERING (2022)

Article Biochemical Research Methods

Dry-compression packing of hydroxyapatite nanoparticles within a flat cuboid chromatography device and its use for fast protein separation

Raja Ghosh, Geoff Hale, Yves Durocher, Paul Gatt

Summary: This study describes a simple dry-compression technique for preparing a flat cuboid chromatography device and discusses its application in fast protein separation. The device allows the separation of binary protein mixtures in a short amount of time, while simultaneously increasing productivity and purity. The suitability of the device for preparative protein separations is demonstrated through the purification of a monoclonal antibody from cell culture supernatant.

JOURNAL OF CHROMATOGRAPHY A (2022)

Article Multidisciplinary Sciences

Structure-based dual affinity optimization of a SARS-CoV-1/2 cross-reactive single-domain antibody

Traian Sulea, Jason Baardsnes, Matthew Stuible, Nazanin Rohani, Anh Tran, Marie Parat, Yuneivy Cepero Donates, Melanie Duchesne, Pierre Plante, Guneet Kour, Yves Durocher

Summary: Researchers have developed improved antibodies against SARS-CoV-2 by enhancing the binding affinity of VHH-72 through structure-based approaches. These mutants have shown increased neutralizing capabilities and are predicted to be valuable in the treatment of COVID-19.

PLOS ONE (2022)

Article Hematology

Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells

Florian Puhm, Isabelle Allaeys, Emile Lacasse, Isabelle Dubuc, Yannick Galipeau, Younes Zaid, Loubna Khalki, Clemence Belleannee, Yves Durocher, Alain R. Brisson, Alisa S. Wolberg, Marc-Andre Langlois, Louis Flamand, Eric Boilard

Summary: Platelets are hyperactivated in COVID-19, but the mechanisms behind platelet activation by SARS-CoV-2 are not well understood. This study found that tissue factor (TF) produced by infected cells can activate platelets. Virions and extracellular vesicles (EVs) were also identified, and TF activity was associated with either the virus or the EVs. Blocking this pathway may interfere with platelet activation and the coagulation characteristics of COVID-19.

BLOOD ADVANCES (2022)

Article Multidisciplinary Sciences

Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters

Felicity C. Stark, Bassel Akache, Lise Deschatelets, Anh Tran, Matthew Stuible, Yves Durocher, Michael J. McCluskie, Gerard Agbayani, Renu Dudani, Blair A. Harrison, Tyler M. Renner, Shawn R. Makinen, Jegarubee Bavananthasivam, Diana Duque, Martin Gagne, Joseph Zimmermann, C. David Zarley, Terrence R. Cochrane, Martin Handfield

Summary: Intranasal delivery of a novel protein subunit vaccine formulation induced robust immune responses in mice and hamsters, with strong neutralizing activity against multiple SARS-CoV-2 variants. This intranasal vaccine formulation has the potential to be a new SARS-CoV-2 vaccine.

SCIENTIFIC REPORTS (2022)

Article Multidisciplinary Sciences

Multi-temperature experiments to ease analysis of heterogeneous binder solutions by surface plasmon resonance biosensing

Jimmy Gaudreault, Yves Durocher, Olivier Henry, Gregory De Crescenzo

Summary: This article discusses the data analysis algorithms and application of Surface Plasmon Resonance (SPR) biosensing. The algorithms can accurately identify kinetic parameters and estimate the composition of mixtures in cases of multiple species interactions, making SPR biosensing a potential tool for bioprocess monitoring.

SCIENTIFIC REPORTS (2022)

Article Immunology

Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern

Erika Rudi, Pablo Martin Aispuro, Eugenia Zurita, Maria M. Gonzalez Lopez Ledesma, Daniela Bottero, Juan Malito, Magali Gabrielli, Emilia Gaillard, Matthew Stuible, Yves Durocher, Andrea V. Gamarnik, Andres Wigdorovitz, Daniela Hozbor

Summary: The study evaluated the immune capacity of vaccine candidates based on different SARS-CoV-2 variants and found that the single S protein from the ancestral Wuhan virus displayed the highest antibody levels and neutralizing antibody titers against different variants. Additionally, this formulation also induced various immune cell responses and antibody levels. When used as a booster dose, it enhanced the immune response against different S protein variants.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern

Bassel Akache, Tyler M. Renner, Matthew Stuible, Nazanin Rohani, Yuneivy Cepero-Donates, Lise Deschatelets, Renu Dudani, Blair A. Harrison, Christian Gervais, Jennifer J. Hill, Usha D. Hemraz, Edmond Lam, Sophie Regnier, Anne E. G. Lenferink, Yves Durocher, Michael J. McCluskie

Summary: Using the SmT1 SARS-CoV-2 spike antigen platform, we developed antigens targeting the Beta and Delta variants. These antigens showed higher neutralizing antibody activity and a multivalent vaccine demonstrated cross-neutralizing activity against all three variants. This suggests that variant-specific antigens may be necessary for optimal immune response and reduction of infection against emerging variants.

NPJ VACCINES (2022)

Article Biology

Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models

Martin A. Rossotti, Henk van Faassen, Anh T. Tran, Joey Sheff, Jagdeep K. Sandhu, Diana Duque, Melissa Hewitt, Xiaoxue Wen, Jegarubee Bavananthasivam, Saina Beitari, Kevin Matte, Genevieve Laroche, Patrick M. Giguere, Christian Gervais, Matthew Stuible, Julie Guimond, Sylvie Perret, Greg Hussack, Marc-Andre Langlois, Yves Durocher, Jamshid Tanha

Summary: This study presents a diverse collection of extensively characterized nanobodies targeting the spike glycoprotein of SARS-CoV-2. These nanobodies show broad neutralization efficacies against SARS-CoV-2 in vitro and in vivo, reducing viral burden by up to six orders of magnitude. They have high affinity, stability, and cross-reactivity, making them promising candidates for developing broad-spectrum therapeutics against current and emerging SARS-CoV-2 variants.

COMMUNICATIONS BIOLOGY (2022)

Article Multidisciplinary Sciences

Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimens

Francois Cholette, Rissa Fabia, Angela Harris, Hannah Ellis, Karla Cachero, Lukas Schroeder, Christine Mesa, Philip Lacap, Corey Arnold, Yannick Galipeau, Marc-Andre Langlois, Karen Colwill, Anne-Claude Gingras, Allison McGeer, Elizabeth Giles, Jacqueline Day, Carla Osiowy, Yves Durocher, Catherine Hankins, Bruce Mazer, Michael Drebot, John Kim

Summary: The extent of the COVID-19 pandemic can be better understood through serosurveys and SARS-CoV-2 antibody testing. Dried blood spot (DBS) samples are crucial for large scale serosurveillance, especially in Canada. This study evaluated the performance of various assays for DBS-based SARS-CoV-2 serosurveillance and found that several assays are suitable with high sensitivity and specificity.

HELIYON (2022)

Article Biochemical Research Methods

A fast, efficient, and scalable method for purifying recombinant SARS-CoV-2 spike protein

Nikhila Butani, Yating Xu, Si Pan, Yves Durocher, Raja Ghosh

Summary: Recombinant SARS-CoV-2 trimeric spike protein, a potential COVID-19 vaccine candidate, is challenging to manufacture on a large scale due to its size. A membrane chromatography-based purification method is proposed in this paper, which provides a fast and scalable approach for manufacturing the spike protein.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2023)

Article Medicine, Research & Experimental

A glyco-engineering approach for site-specific conjugation to Fab glycans

Maria L. Jaramillo, Traian Sulea, Yves Durocher, Mauro Acchione, Melissa J. Schur, Anna Robotham, John F. Kelly, Marie-France Goneau, Alma Robert, Yuneivy Cepero-Donates, Michel Gilbert

Summary: Effective processes for synthesizing antibody-drug conjugates (ADCs) require site-specific incorporation of the payload, optimal drug/antibody ratio, and a homogeneous product. Conventional ADCs often face issues like interference with epitope binding and product heterogeneity. This study presents a more controlled process where the drug is specifically conjugated to Fab N-linked glycans, resulting in ADCs with desired drug/antibody ratio and efficient targeting.
Article Immunology

Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice

Mariam Maltseva, Yannick Galipeau, Tyler M. Renner, Lise Deschatelets, Yves Durocher, Bassel Akache, Marc-Andre Langlois

Summary: Continuous viral evolution of SARS-CoV-2 has led to variants capable of immune evasion, vaccine breakthrough infections, and increased transmissibility. Intranasal administration of adjuvanted protein subunit vaccines can induce robust immune responses in mice, producing antibodies against the virus.

VACCINES (2023)

Article Medicine, Research & Experimental

Affinity-controlled capture and release of engineered monoclonal antibodies by macroporous dextran hydrogels using coiled-coil interactions

Seyed Farzad Baniahmad, Romane Oliverio, Ines Obregon-Gomez, Alma Robert, Anne E. G. Lenferink, Elena Pazos, Nick Virgilio, Xavier Banquy, Gregory De Crescenzo, Yves Durocher

Summary: Long-term delivery is a successful strategy to reduce adverse effects of mAb-based treatments. Macroporous hydrogels and affinity-based strategies are effective in sustained and localized delivery of mAbs. The Ecoil and Kcoil peptides have high-affinity binding and can be used for controlled release of Ecoil-tagged trastuzumab from macroporous hydrogels.
Article Immunology

A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination

Karen Colwill, Yannick Galipeau, Matthew Stuible, Christian Gervais, Corey Arnold, Bhavisha Rathod, Kento T. Abe, Jenny H. Wang, Adrian Pasculescu, Mariam Maltseva, Lynda Rocheleau, Martin Pelchat, Mahya Fazel-Zarandi, Mariam Iskilova, Miriam Barrios-Rodiles, Linda Bennett, Kevin Yau, Francois Cholette, Christine Mesa, Angel X. Li, Aimee Paterson, Michelle A. Hladunewich, Pamela J. Goodwin, Jeffrey L. Wrana, Steven J. Drews, Samira Mubareka, Allison J. McGeer, John Kim, Marc-Andre Langlois, Anne-Claude Gingras, Yves Durocher

Summary: This study describes a scalable solution to detect and quantify SARS-CoV-2 antibodies, discriminate between natural infection and vaccination-induced responses, and assess the inhibitory effect of antibodies on ACE2-spike interaction. They developed methods and reagents for antibody detection using ELISA and snELISA, enabling large-scale analysis. In addition, they provided detailed protocols for the experiments.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2022)

暂无数据